FDA campaign F-0626-2025
Class IIHazard
The firm received complaints of spoilage and illness with the use of the products.
Distribution
The product was shipped to the following states: AL, AR, CO, CT, FL, GA, IL, IN, KY, LA, MD, ME, MI, MN, MO, MS, NC, NE, NH, NJ, NM, NY, OH, OK, PA, SC, TN, TX, VA, WI & WY.
REKALLD area-alert coverage: AL, AR, CO, CT, FL, GA, IL, IN, KY, LA, MD, ME, MI, MN, MO, MS, NC, NE, NH, NJ, NM, NY, OH, OK, PA, SC, TN, TX, VA, WI, WY (our reading of the distribution above)
The text above is quoted verbatim from the FDA record. Confirm the affected units and the remedy with the manufacturer or FDA. Recall data may be incomplete, delayed, or superseded.